{"id":"folferi","rwe":[],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"},{"label":"Sherief Abd-Elsalam","category":"company"}],"phase":"marketed","safety":{},"trials":[],"aliases":[],"company":"Sherief Abd-Elsalam","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=FOLFERI","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:43:12.478175+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:43:18.126970+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=FOLFERI","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:43:18.461649+00:00"}},"allNames":["folferi"],"offLabel":[],"synonyms":[],"timeline":[],"approvals":[],"ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"","oneSentence":"","technicalDetail":"Folferi's mechanism of action is not well understood, but it is believed to involve the modulation of a specific biological pathway or target, leading to a therapeutic effect."},"commercial":{},"references":[{"id":1,"url":"https://clinicaltrials.gov/search?intr=folferi","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=folferi","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-31T10:29:01.457121","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:43:20.598782+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[],"genericName":"folferi","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT03645187","phase":"PHASE4","title":"Celecoxib as Adjuvant Therapy to Chemotherapy in Patients With Metastatic Colorectal Cancer","status":"UNKNOWN","sponsor":"Sherief Abd-Elsalam","startDate":"2018-08-01","conditions":["Colon Cancer Stage"],"enrollment":50,"completionDate":"2025-12"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"formularyStatus":[],"_enricherVersion":"v2-openfda","developmentCodes":[],"ownershipHistory":[{"period":"","companyName":"Sherief Abd-Elsalam","relationship":"Original Developer"}],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"originalDeveloper":"Sherief Abd-Elsalam","recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"FOLFERI","companyName":"Sherief Abd-Elsalam","companyId":"sherief-abd-elsalam","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:43:20.598782+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}